Cargando…
Phenytoin and carbamazepine in trigeminal neuralgia: marketing-based versus evidence-based treatment
Autores principales: | Keppel Hesselink, Jan M, Schatman, Michael E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522676/ https://www.ncbi.nlm.nih.gov/pubmed/28761370 http://dx.doi.org/10.2147/JPR.S141896 |
Ejemplares similares
-
Topical phenytoin for the treatment of neuropathic pain
por: Kopsky, David J, et al.
Publicado: (2017) -
Phenytoin Cream for the Treatment of Neuropathic Pain: Case Series
por: Kopsky, David J., et al.
Publicado: (2018) -
Drug-Induced Hypersensitivity Syndrome Caused by Carbamazepine Used for the Treatment of Trigeminal Neuralgia
por: Ono, Yuko, et al.
Publicado: (2016) -
“But that is your opinion”: the dark side of postmodern pain medicine creating a postmodern patient autonomy
por: Hesselink, Jan M Keppel, et al.
Publicado: (2018) -
EHMTI-0355. Comparison of carbamazepine and oxcarbazepine tolerability in patients with trigeminal neuralgia
por: Cregg, R, et al.
Publicado: (2014)